#739861
Pleananna rialaithe náisiúnta ilbhliantúla (MANCP) agus comhlacht aonair do MANCP
Multi-annual national control plans (MANCP) and a single body for the MANCP
Pleananna rialaithe náisiúnta ilbhliantúla (MANCP) agus comhlacht aonair do MANCP
Multi-annual national control plans (MANCP) and a single body for the MANCP
a áirithiú gur MANCP comhleanúnach a bheidh ann;
ensuring that the MANCP is coherent;
torthaí rialuithe oifigiúla a rinneadh an bhliain roimhe sin faoina MANCP;
the outcome of official controls performed in the previous year under its MANCP;
Ba cheart na híosmhinicíochtaí samplála sin a chur san áireamh i MANCP.
Those minimum sampling frequencies should be included in the MANCP.
ÁBHAR SONRACH BREISE AN MANCP
SPECIFIC ADDITIONAL CONTENT OF THE MANCP
Áiritheoidh na Ballstáit go ndéanfaidh na húdaráis inniúla na rialuithe oifigiúla arna rialú ag an Rialachán seo ar bhonn MANCP, agus déanfar ullmhú agus cur chun feidhme an MANCP a chomhordú ar fud a gcríche.
Member States shall ensure that official controls governed by this Regulation are performed by the competent authorities on the basis of a MANCP, the preparation and implementation of which are coordinated across their territory.
Thairis sin, le Rialachán (AE) 2017/625, sonraítear ábhar ginearálta MANCP, lena n-áirítear an ceanglas ar na Ballstáit foráil a dhéanamh ina MANCP maidir le rialuithe oifigiúla ar úsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de atá údaraithe mar tháirgí íocshláinte tréidliachta nó mar bhreiseáin bheathaithe agus ar úsáid substaintí toirmiscthe nó neamhúdaraithe atá gníomhach ó thaobh na cógaseolaíochta de agus ar úsáid iarmhar díobh.
Regulation (EU) 2017/625 furthermore specifies the general content of the MANCP, including the requirement for Member States to provide in their MANCP official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof.
Thairis sin, le Rialachán (AE) 2017/625, sonraítear ábhar ginearálta an MANCP, lena n-áirítear an ceanglas ar na Ballstáit foráil a dhéanamh ina MANCP maidir le rialuithe oifigiúla ar úsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de atá údaraithe mar tháirgí íocshláinte tréidliachta nó mar bhreiseáin bheathaithe agus ar úsáid substaintí toirmiscthe nó neamhúdaraithe atá gníomhach ó thaobh na cógaseolaíochta de agus ar úsáid iarmhar díobh.
Regulation (EU) 2017/625 furthermore specifies the general content of the MANCP, including the requirement for Member States to provide in their MANCP official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof.
socruithe sonracha agus ábhar sonrach sa bhreis orthu sin dá bhforáiltear in Airteagal 110, chun na codanna ábhartha den phlean náisiúnta rialaithe ilbhliantúil (MANCP) dá bhforáiltear in Airteagal 109(1) a ullmhú;
specific additional arrangements and specific additional content to those provided for in Article 110, for the preparation of the relevant parts of the multi-annual national control plan (MANCP) provided for in Article 109(1);
ullmhú an MANCP a chomhordú idir na húdaráis inniúla ar fad atá freagrach as na rialuithe oifigiúla;
coordinating the preparation of the MANCP across all competent authorities responsible for the official controls;
cuspóirí straitéiseacha MANCP agus faisnéis maidir leis an gcaoi a bhfreagraíonn tosaíocht do rialuithe oifigiúla agus leithdháileadh acmhainní do na cuspóirí sin;
the strategic objectives of the MANCP and on how the prioritisation of official controls and allocation of resources reflect these objectives;
Cuirfidh na Ballstáit, arna iarraidh sin dóibh, an leagan cothrom le dáta is déanaí dá MANCP faoi seach ar fáil don Choimisiún arna iarraidh sin orthu.
Member States shall provide the Commission, upon request, with the latest up-to-date version of their respective MANCP.
aon leasuithe arna ndéanamh ar MANCP chun na tosca dá dtagraítear in Airteagal 111(2) a chur san áireamh;
any amendments made to its MANCP to take account of the factors referred to in Article 111(2);
Le hAirteagal 109 den Rialachán sin, cuirtear d’oibleagáid ar na Ballstáit a áirithiú gur ar bhonn plean rialaithe náisiúnta ilbhliantúil (“MANCP”) a dhéanfaidh na húdaráis inniúla na rialuithe oifigiúla.
Article 109 of that Regulation obliges Member States to ensure that official controls are performed by the competent authorities on the basis of a multi-annual national control plan (‘MANCP’).
Le hAirteagal 109 den Rialachán sin, cuirtear d’oibleagáid ar na Ballstáit a áirithiú gur ar bhonn plean rialaithe náisiúnta ilbhliantúil (“MANCP”) a dhéanfaidh na húdaráis inniúla na rialuithe oifigiúla.
Article 109 of that Regulation obliges Member States to ensure that official controls are performed by the competent authorities on the basis of a multi-annual national control plan (‘MANCP’).
Chun íosmhinicíocht aonfhoirmeach rialuithe a ráthú, ba cheart a shainiú sa Rialachán seo na híosmhinicíochtaí rialaithe a bheidh le háireamh sa MANCP.
In order to guarantee a uniform minimum frequency of controls, this Regulation should define minimum control frequencies to be included in the MANCP.
Ba cheart é a bheith de cheangal ar gach Ballstát plean rialaithe náisiúnta ilbhliantúil (MANCP) a bhunú agus a thabhairt cothrom le dáta go rialta, lena gcumhdófaí na réimsí ar fad arna rialú le reachtaíocht an Aontais maidir leis an slabhra agraibhia agus ina mbeadh faisnéis faoi struchtúr agus faoi eagrú a chórais rialuithe oifigiúla.
Each Member State should be required to set up and regularly update a multi-annual national control plan (MANCP) covering all the areas governed by Union agri-food chain legislation and containing information on the structure and organisation of its system of official controls.
D’fhonn comhleanúnachas agus iomláine MANCPanna a áirithiú, ba cheart do gach Ballstát comhlacht amháin a ainmniú a gcuirfear de chúram air ullmhú a MANCP féin a chomhordú agus an fhaisnéis faoina chur chun feidhme, athbhreithniú agus a chothromú le dáta a bhailiú, de réir mar is gá.
In order to ensure the coherence and completeness of the MANCP each Member State should designate a single body tasked with coordinating the preparation of its MANCP and collecting, as necessary, the information on its implementation, review and update.
bailiú na faisnéise maidir le cur chun feidhme an MANCP i bhfianaise an tuairisciú bliantúil dá dtagraítear in Airteagal 113 a thíolacadh agus a athbhreithniú agus a thabhairt cothrom le dáta de réir mar is gá i gcomhréir le hAirteagal 111(2).
collecting the information on the implementation of the MANCP in view of submitting the annual reporting referred to in Article 113 and of its review and update as necessary in accordance with Article 111(2).
Tabharfar MANCP cothrom le dáta go rialta chun é a chur in oiriúint d’athruithe ar na rialacha dá dtagraítear in Airteagal 1(2), agus déanfar athbhreithniú air chun na tosca seo a leanas ar a laghad a chur san áireamh:
The MANCP shall be regularly updated to adjust it to changes to the rules referred to in Article 1(2), and reviewed to take account at least of the following factors:
Le Rialachán Cur Chun Feidhme (AE) 2022/1646 ón gCoimisiún, leagtar síos na socruithe praiticiúla aonfhoirmeacha chun rialuithe oifigiúla a dhéanamh a mhéid a bhaineann le húsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de atá údaraithe mar tháirgí íocshláinte tréidliachta nó mar bhreiseáin bheathaithe agus le húsáid substaintí toirmiscthe nó neamhúdaraithe atá gníomhach ó thaobh na cógaseolaíochta de agus le húsáid iarmhar díobh, agus sonraítear ann freisin ábhar agus socruithe MANCP a mhéid a bhaineann leis na substaintí agus na hiarmhair sin.
Commission Implementing Regulation (EU) 2022/1646 lays down the uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof and also specifies the content and arrangements of the MANCP as regards these substances and residues
Áirithítear leis an Rialachán seo leanúnachas na rialacha a leagtar síos i dTreoir 96/23/CE ón gComhairle maidir le hábhar an MANCP lena ullmhú, chomh maith le híosmhinicíocht na rialuithe oifigiúla a mhéid a bhaineann le rialuithe oifigiúla ar iarmhair substaintí a ngabhann gníomhaíocht cógaseolaíochta leo, ar iarmhair a meitibilítí agus ar iarmhair substaintí eile atá in-tarchurtha chuig táirgí ainmhithe agus ar dócha go ndéanfadh siad dochar do shláinte an duine.
This Regulation ensures the continuity of the rules laid down in Directive 96/23/EC concerning the content of the MANCP and its preparation, as well as the minimum frequency of official controls, as regards official controls of residues of substances having a pharmacological action, of their metabolites and of other substances transmissible to animal products that are likely to be harmful to human health.
Áireofar na rialuithe sin i MANCP gach Ballstáit agus beidh trí phlean iontu: plean rialaithe rioscabhunaithe i ndáil le táirgeadh sa Bhallstát, plean rialaithe rioscabhunaithe i ndáil le hallmhairí tríú tíortha, agus, d’fhonn faisnéis a bhailiú a bheidh úsáideach chun rialuithe rioscabhunaithe i ndáil le táirgeadh sna Ballstáit sa todhchaí a dhíriú, ba cheart do na Ballstáit plean faireachais randamaithe a áireamh.
Those controls shall be included in each Member State’s MANCP and comprise three plans: a risk-based control plan for production in the Member State, a risk-based control plan for third-country imports, and, in order to collect information useful to orientate future risk-based controls for production in the Member States, Member States should include a randomised surveillance plan.
Sa bhreis ar rialuithe maidir le tairgeadh na mBallstát, ba cheart do na Ballstáit plean rialaithe i leith táirgí a bhfuil sé beartaithe iad a thabhairt isteach san Aontas ó thríú tíortha a áireamh ina MANCP agus é sin a dhéanamh chun éifeachtacht rialuithe iarmhar na dtríú tíortha a fhíorú agus chun a fhíorú go gcomhlíonann táirgí allmhairithe de bhunadh ainmhíoch rialacha an Aontais.
In addition to controls on Member States’ production, Member States should include a control plan for products, which are intended for the entry into the Union from third countries in their MANCP in order to verify the effectiveness of third countries’ residue controls and the compliance of imported products of animal origin with the Union rules.
Chun a áirithiú go mbeidh ábhar comhchuibhithe agus cuimsitheach sa MANCP maidir le húsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de agus atá údaraithe mar tháirgí íocshláinte tréidliachta nó mar bhreiseáin beatha agus úsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de atá toirmiscthe nó neamhúdaraithe i mbia-ainmhithe agus iarmhair na substaintí sin in ainmhithe agus i dtáirgí de bhunadh ainmhíoch, ba cheart gnéithe ábhartha a ábhar a shainiú.
In order to ensure a harmonised and comprehensive content of the MANCP on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances in food-producing animals and residues thereof in animals and products of animal origin, the relevant aspects of its content should be defined.
socruithe sonracha breise agus ábhar sonrach breise le haghaidh plean rialaithe ilbhliantúla náisiúnta na mBallstát (“MANCP”), sa bhreis ar na socruithe sin agus ar an ábhar sin dá bhforáiltear in Airteagal 110 de Rialachán (AE) 2017/625.
specific additional arrangements and specific additional content for the Member States’ multi-annual national control plan (‘MANCP’), in addition to those provided for in Article 110 of Regulation (EU) 2017/625.
Áiritheoidh na Ballstáit go bhfuil an méid seo a leanas sa chuid den MANCP a bhaineann le feidhmiú rialuithe oifigiúla ar úsáid substaintí atá gníomhach ó thaobh na cógaseolaíochta de atá údaraithe mar tháirgí íocshláinte tréidliachta nó mar bhreiseáin bheathaithe agus úsáid substaintí toirmiscthe nó neamhúdaraithe atá gníomhach ó thaobh na cógaseolaíochta de agus iarmhar díobh in ainmhithe beo agus i dtáirgí de bhunadh ainmhíoch:
Member States shall ensure that the part of the MANCP concerning the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof in live animals and products of animal origin contains the following:
De bhun Airteagal 111(2) de Rialachán (AE) 2017/625, le linn don MANCP a bheith á chur i gcrích, déanfaidh na Ballstáit athbhreithniú ar an bplean rioscabhunaithe náisiúnta i ndáil le táirgeadh sna Ballstáit chun cóireálacha neamhdhleathacha, go háirithe iad siúd a aithnítear tríd an bplean faireachais.
Pursuant to Article 111(2) of Regulation (EU) 2017/625, during the course of the execution of the MANCP, Member States shall review the national risk-based plan for production in the Member States to take account of illegal treatments identified, in particular, through the surveillance plan.
I gcomhréir le hAirteagal 110(2) de Rialachán (AE) 2017/625 ní gá do na Ballstáit faisnéis a soláthraíodh cheana sa chuid ghinearálta den MANCP nó a bhfuil tuairisc uirthi i reachtaíocht an Aontais a chur isteach.
Member States do not need submit information already provided in the general part of the MANCP or described in Union legislation according to Article 110(2) of Regulation (EU) 2017/625.